Related Experiment Videos
Indications and use of the Palmaz-Schatz coronary stent
1Division of Cardiology, Scripps Clinic and Research Foundation, La Jolla, California.
Insights
Coronary artery restenosis remains a challenge in interventional cardiology. The Palmaz-Schatz stent significantly reduces restenosis in new coronary lesions, offering a promising solution.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- Restenosis, the re-narrowing of arteries after angioplasty, is a major complication in interventional cardiology.
- Balloon angioplasty, while standard for ischemic syndromes, has a significant restenosis rate.
- The development of novel catheter-based treatments is crucial for preventing restenosis.
Purpose of the Study:
- To evaluate the efficacy of the Palmaz-Schatz stent in preventing restenosis.
- To compare stent intervention with traditional angioplasty in managing coronary artery disease.
Main Methods:
- Analysis of data from randomized trials (STRESS and BENESTENT).
- Inclusion of de novo coronary lesions and saphenous vein bypass grafts in study populations.
- Assessment of angiographic restenosis rates post-intervention.
Main Results:
- The Palmaz-Schatz stent demonstrated a significant reduction in angiographic restenosis in de novo coronary lesions.
- Nonrandomized trials indicated potential benefits of the stent in saphenous vein bypass grafts.
Conclusions:
- The Palmaz-Schatz stent represents a significant advancement in preventing restenosis after coronary interventions.
- Further investigation into stent use in bypass grafts may yield additional benefits.
Abstract:
Restenosis prevention has been the 'holy grail' of contemporary interventional cardiology. Even though balloon angioplasty has become the standard treatment for ischemic syndromes, it is still plagued by a definite incidence of restenosis. This recidivism has prompted the search for newer, catheter-based modalities of treatment to address this issue. The proliferation of newer devices for intervention has increased the number of options for the interventional cardiology; however, until recently, none has had a significant impact on restenosis. The randomized trials (STRESS and BENESTENT) have both shown a significant reduction in angiographic restenosis with the Palmaz-Schatz stent in de novo coronary lesions. Nonrandomized trials suggest additional benefit in saphenous vein bypass grafts.